Form 483

Actavis Laboratories UT, Inc. Form 483, 2025-09-19

FDA issued a Form 483 to Actavis Laboratories UT, Inc. on 2025-09-19 with 4 public-safe observations.

483· Form 483 issuedHuman Drugs4 observations

Actavis Laboratories UT, Inc. · Salt Lake City, United States · Issued September 19, 2025

Overview

  • 4 public-safe observations are available for this inspection.
  • 4 structured CFR citations are represented.
  • 2 investigators are tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

19 Sep 2025
21 CFR 211.113(a)

Procedures for non-sterile drug products

Cited by Brittny C Cargo, Luis P Torres

19 Sep 2025
21 CFR 211.192

Written record of investigation incomplete

Cited by Brittny C Cargo, Luis P Torres

19 Sep 2025
21 CFR 211.56(a)

Sanitation--buildings not clean, free of infestation

Cited by Brittny C Cargo, Luis P Torres

19 Sep 2025
21 CFR 211.63

Equipment Design, Size and Location

Cited by Brittny C Cargo, Luis P Torres

Inspected site

ALActavis Laboratories UT, Inc.Salt Lake City, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.113(a)Cited across public-safe Form 483 observations1x
21 CFR 211.192Cited across public-safe Form 483 observations1x
21 CFR 211.56(a)Cited across public-safe Form 483 observations1x
21 CFR 211.63Cited across public-safe Form 483 observations1x

Source document

PDF
PDF available

Form 483 source document

The source document is available to authorized Atlas users.

Full 483 report

Get the verbatim text of all 4 observations

The source PDF, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere